| Name | Title | Contact Details |
|---|
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
Cancer CarePoint Inc is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Cancer CarePoint Inc is based in Decatur, GA. You can find more information on Cancer CarePoint Inc at www.cancercarepoint.com
HealthSTAR Communications, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Health Partners Plans is a health insurance organization serving more than 267,456 members in Southeastern Pennsylvania. Founded more than 30 years ago, Health Partners Plans offers Medicaid, Medicare and Children`s Health Insurance Program (CHIP) plans that include special benefits to improve the health and wellness of our members. We`re also committed to boosting the health of our community through outreach, education and events. Health Partners Plans is one of the few hospital-owned health maintenance organizations in the country. We continually develop new ways to encourage better health outcomes and have received national recognition for our innovations in managed care.
SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.